|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues from company-owned or managed clinics | |||||
| Royalty fees | |||||
| Franchise | |||||
| Advertising fund revenue | |||||
| Software fees | |||||
| Other revenues | |||||
| Total revenues | |||||
| Cost of revenues: | |||||
| Cost of revenues | |||||
| Franchise | |||||
| Software fees | |||||
| Total cost of revenues | |||||
| Selling and marketing expenses | |||||
| Depreciation and amortization | |||||
| General and administrative expenses | |||||
| Total selling, general and administrative expenses | |||||
| Net loss on disposition or impairment | |||||
| Loss from continuing operations | |||||
| Other income, net | |||||
| Loss from continuing operations before income tax expense | |||||
| Income tax expense | |||||
| Net loss from continuing operations | |||||
| Discontinued operations: | |||||
| Income (loss) from discontinued operations before income tax expense | |||||
| Income tax expense from discontinued operations | |||||
| Net income (loss) from discontinued operations | |||||
| Net income (loss) | |||||
| Net (loss) income from continuing operations per common share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Net income (loss) from discontinued operations per common share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Net income (loss) per common share: | |||||
| Net income (loss) per common share, basic (in dollars per share) | |||||
| Net income (loss) per common share, diluted (in dollars per share) | |||||
| Basic weighted average shares outstanding (in shares) | |||||
| Diluted weighted average shares outstanding (in shares) | |||||
Loading...